Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating factors affecting participation in heart failure care interventions

Official title: Research Into Factors Determining Participation in Two Interventions Modifying the Care Pathways of Patients With Heart Failure in Eastern Occitanie: PRADO-IC and Telemedicine

Run by University Hospital, Montpellier · NCT05417490 · Data updated 2026-11-12

This study looks at how factors affect whether heart failure patients who just left the hospital join two different programs designed to help them get better care at home and avoid going back to the hospital.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedApril 1, 2025
Main results expectedApril 1, 2027
Study endsApril 1, 2027
Registry record updatedApril 15, 2026
Trial IDNCT05417490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults hospitalized for heart failure or related conditions who agree to participate.

Probably not a fit

Patients who are pregnant, breastfeeding, unable to provide consent, or legally detained may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with heart failure who have recently been hospitalized. It evaluates two interventions aimed at improving care coordination during the transition from hospital to home: the PRADO program, which provides outpatient medical and nursing follow-up, and a telemedicine initiative for remote monitoring. The study aims to understand the factors influencing patient participation in these interventions and their potential impact on reducing rehospitalizations and mortality rates. By analyzing patient experiences and outcomes, the research seeks to enhance the effectiveness of heart failure management.

Why it matters

Potential benefit: If successful, this study could lead to improved care pathways for heart failure patients, reducing hospital readmissions and mortality.

How similar studies have gone: Preliminary studies have shown success with similar interventions in reducing rehospitalizations and mortality in heart failure patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient
* Patient hospitalized at the time of inclusion for cardiac decompensation, or cause of admission for which heart failure plays a decisive or aggravating role (co-infection, etc.) recognized by the clinician.
* Patient agreeing to take part in this research (absence of non-objection)

Exclusion Criteria:

* Refusal to participate
* Pregnant or breastfeeding women, patients unable to give protected adult consent, vulnerable people (art.L.1121-6, L.1121-7, L.1211-8, L.1211-9)
* Subject deprived of liberty by judicial or administrative decision

Where it's running

  • University Hospital, Montpellier
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.